arepanrix: Clinical Trials

8 trials of arepanrix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 active not recruiting. 5 Phase 4, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Active not recruiting 1
Phase 32Active not recruiting 1, Completed 1

Follow arepanrix: new trials by email Literature Review of arepanrix trials Research Report on arepanrix

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)
H5N1 vaccine (Arepanrix, GSK), Placebo - Influenza (Pandemic), Avian Influenza
Phase 3Active not recruitingUniversity Health Network, Toronto1202025-11-032026-10-23
Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart
H5N1 vaccine (Arepanrix), Saline (as a placebo) - H5N1 Influenza, H5N1 Virus
Phase 4Active not recruitingCanadian Immunization Research Network3122025-10-142026-01-16
Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older
Arepanrix™ - Influenza
Phase 4CompletedGlaxoSmithKline502010-05-172019-11-05
Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age
GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations), GSK Biologicals' investigational vaccine GSK2340273A (alternative formulations), Placebo - Influenza
Phase 3CompletedGlaxoSmithKline61542010-02-122021-02-26
Drug Use Investigation for Arepanrix® (H1N1)
Arepanrix® - Influenza
CompletedGlaxoSmithKline34052010-02-012014-02-24
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV
Arepanrix - HIV Infections, H1N1 Influenza
Phase 4CompletedUniversity of British Columbia1502010-02-012015-04-15
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults
Arepanrix - H1N1/2009 Influenza
Phase 4CompletedDavid Scheifele1562009-11-012015-04-10
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine
Arepanrix, Vaxigrip 2009/2010 - Influenza, H1N1 2009 Influenza
Phase 4CompletedDavid Scheifele3092009-11-012015-04-10

Conditions studied

Influenza, Human (7)  ·  Influenza in Birds (2)  ·  HIV Infections (1)  ·  Orthomyxoviridae Infections (1)

Sponsors

GlaxoSmithKline (3)  ·  David Scheifele (2)  ·  Canadian Immunization Research Network (1)  ·  University Health Network, Toronto (1)  ·  University of British Columbia (1)

Countries

Canada (5)  ·  Australia (1)  ·  Brazil (1)  ·  Colombia (1)  ·  Costa Rica (1)  ·  Japan (1)  ·  Mexico (1)  ·  Philippines (1)  ·  Singapore (1)  ·  Thailand (1)

Top investigators

David Scheifele, MD (3)  ·  Allison McGeer, MD (2)  ·  Brian Ward, MD (1)  ·  Curtis Cooper, MD (1)  ·  David Hasse, MD (1)  ·  Ethan Rubinstein, MD (1)  ·  Gerald Predy, MD (1)  ·  Ian Gemmill, MD (1)  ·  Joanne M Langley (1)  ·  Laura Sauve, MD (1)  ·  Marc Dionne, MD (1)  ·  Marina Klein, MD (1)  ·  Mark Loeb, MD (1)  ·  Sharon Walmsley, MD (1)

Results publications

PMID 21788422, PMID 22306585, PMID 22652402, PMID 27667752